Deutsche Bank Ag\ Calliditas Therapeutics Ab Transaction History
Deutsche Bank Ag\
- $212 Billion
- Q1 2024
A detailed history of Deutsche Bank Ag\ transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Deutsche Bank Ag\ holds 50,550 shares of CALT stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,550
Previous 50,550
-0.0%
Holding current value
$1.97 Million
Previous $1.3 Million
18.37%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CALT
# of Institutions
24Shares Held
871KCall Options Held
1.5KPut Options Held
32.4K-
Bvf Inc San Francisco, CA750KShares$29.2 Million0.47% of portfolio
-
Ironwood Investment Management LLC Boston, MA25.5KShares$994,6730.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il14.6KShares$569,0200.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA10.3KShares$400,7000.0% of portfolio
-
Morgan Stanley New York, NY5.99KShares$233,3940.0% of portfolio
About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.04B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...